Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE-AF).
North Africa
anticoagulation
atrial fibrillation
management
outcomes
risk scores
Journal
Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
18
01
2021
received:
08
10
2020
accepted:
27
01
2021
pubmed:
12
3
2021
medline:
16
10
2021
entrez:
11
3
2021
Statut:
ppublish
Résumé
Contemporary registries on atrial fibrillation (AF) are scare in North African countries. In the context of the epidemiological transition, prevalence of valvular AF in Tunisia has decreased and the quality of management is still suboptimal. NATURE-AF is a prospective Tunisian registry, involving consecutive patients with AF from March 1, 2017 to May 31, 2017, with a one-year follow-up period. All the patients with an Electrocardiogram-documented AF, confirmed in the year prior to enrolment were eligible. The epidemiological characteristics and outcomes were described. A total of 915 patients were included in this study, with a mean age of 64.3 ± 22 years and a male/female sex ratio of 0.93. Valvular AF was identified in 22.4% of the patients. The mean CHA NATURE-AF has provided systematic collection of contemporary data regarding the epidemiological and clinical characteristics as well as the management of AF by cardiologists in Tunisia. Valvular AF is still prevalent and the quality of anticoagulation was suboptimal.
Sections du résumé
BACKGROUND
BACKGROUND
Contemporary registries on atrial fibrillation (AF) are scare in North African countries.
HYPOTHESIS
OBJECTIVE
In the context of the epidemiological transition, prevalence of valvular AF in Tunisia has decreased and the quality of management is still suboptimal.
METHODS
METHODS
NATURE-AF is a prospective Tunisian registry, involving consecutive patients with AF from March 1, 2017 to May 31, 2017, with a one-year follow-up period. All the patients with an Electrocardiogram-documented AF, confirmed in the year prior to enrolment were eligible. The epidemiological characteristics and outcomes were described.
RESULTS
RESULTS
A total of 915 patients were included in this study, with a mean age of 64.3 ± 22 years and a male/female sex ratio of 0.93. Valvular AF was identified in 22.4% of the patients. The mean CHA
CONCLUSIONS
CONCLUSIONS
NATURE-AF has provided systematic collection of contemporary data regarding the epidemiological and clinical characteristics as well as the management of AF by cardiologists in Tunisia. Valvular AF is still prevalent and the quality of anticoagulation was suboptimal.
Identifiants
pubmed: 33704830
doi: 10.1002/clc.23558
pmc: PMC8027580
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
501-510Informations de copyright
© 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Références
Tunis Med. 2003;81 Suppl 8:625-31
pubmed: 14608750
Am Heart J. 2012 Jan;163(1):13-19.e1
pubmed: 22172431
Tunis Med. 2019 Jan;97(1):113-121
pubmed: 31535702
J Am Heart Assoc. 2013 Jul 18;2(4):e000110
pubmed: 23868192
Heart. 2014 Oct;100(20):1625-35
pubmed: 25106421
PLoS One. 2016 Jan 22;11(1):e0147536
pubmed: 26800084
Eur Heart J. 2014 Dec 14;35(47):3365-76
pubmed: 25176940
Thromb Haemost. 1993 Mar 1;69(3):236-9
pubmed: 8470047
Clin Cardiol. 2021 Apr;44(4):501-510
pubmed: 33704830
Arch Cardiovasc Dis. 2014 Feb;107(2):77-87
pubmed: 24556189
Nat Rev Cardiol. 2014 Nov;11(11):639-54
pubmed: 25113750
Heart. 2010 Dec;96(23):1878-82
pubmed: 21062777
Cardiovasc J Afr. 2018 May/Jun;29(3):139-145
pubmed: 30067272
J Cardiol. 2011 Jan;57(1):95-9
pubmed: 20934857
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Expert Rev Cardiovasc Ther. 2012 Mar;10(3):283-91
pubmed: 22390799
JMIR Res Protoc. 2018 Oct 15;7(10):e181
pubmed: 30322836
Circulation. 2014 Apr 15;129(15):1568-76
pubmed: 24463370
Lancet Glob Health. 2014 Dec;2(12):e717-26
pubmed: 25433627
Clin Epidemiol. 2011 Feb 22;3:67-84
pubmed: 21386976
Am J Med. 2017 Feb;130(2):135-145
pubmed: 27746290
Europace. 2009 Apr;11(4):423-34
pubmed: 19153087
Am J Med. 2015 Dec;128(12):1306-13.e1
pubmed: 26239094
Eur Heart J. 2005 Nov;26(22):2422-34
pubmed: 16204266
Int J Gen Med. 2015 Jul 31;8:231-42
pubmed: 26261423
Europace. 2014 Mar;16(3):308-19
pubmed: 24351881
Circ J. 2013;77(9):2264-70
pubmed: 23708863
Europace. 2015 Dec;17(12):1777-86
pubmed: 26321406
Eur Heart J. 2008 May;29(9):1181-9
pubmed: 18397874
Europace. 2014 Jan;16(1):6-14
pubmed: 24084680